460 Studies Now Enrolling
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Study to Help Develop Tailored Breast Cancer Screening Strategies
| Sponsor: | National Cancer Institute |
| Enrolling: | Female Patients Only |
| IRB Number: | AAAR5344 |
| U.S. Govt. ID: | NCT03233191 |
| Contact: | Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu |
Additional Study Information:
We are currently recruiting women to TMIST, a clinical trial that will help us develop strategies that tailor breast cancer screening to the risks of individual women. This is a screening trial. The purpose of this trial is to determine if tomosynthesis (3-D) mammography detects breast cancer at earlier stage than current method of 2-D digital mammography.
This study is closed
Do You Qualify?
| Are you a woman between the ages of 45 and 74? | Yes | No |
| Are you scheduled for a screening mammogram and you have not had a screening mammogram in the last 11 months? | Yes | No |
| Are you pregnant, intend to be pregnant, or lactating? | Yes | No |
| Do you have symptoms of breast disease or have a history of breast cancer? | Yes | No |
| Do you currently have breast implants or other breast enhancements? | Yes | No |